| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_69f43505d1b3ec31c224b32b5d1ec4e2 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-63
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y503-04001
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-245
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-90
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-475 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-90
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-63
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-245
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-475 |
| filingDate |
2015-10-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2017-04-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5d081393d16f0d8ed9681cf4dd708254
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dd489b767e960d6d68348b9b950d17c3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cc53ff9088c23d1e3002b50abce0ebba |
| publicationDate |
2017-04-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-101723306-B1 |
| titleOfInvention |
Soluble overexpression and purification method of active recombinant human vascular endothelial growth factor |
| abstract |
The present invention relates to a water-soluble overexpression and purification method of a human vascular endothelial growth factor (hVEGF) having a biological activity, and a recombinant expression vector containing a solubility enhancing tag and hVEGF gene is provided do. Also provided is a recombinant microorganism transformed with the recombinant expression vector, and provides a method for producing the hVEGF recombinant protein. The purified hVEGF protein according to the present invention is expected to play an important role as a broad therapeutic agent for angiogenesis related diseases. |
| priorityDate |
2015-10-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |